Brown advocates for cheaper insulin in Lowellville

Senator Brown’s Fight to Lower Insulin Prices

Senator Brown’s Commitment to Affordable Insulin

U.S. Senator Sherrod Brown (D-OH) recently teamed up with pharmacist Ray Carlson and Ohioans Mike and Kathleen Heinzer to discuss the significant impact of the $35 monthly cap on insulin prices. This cap, made possible by the Inflation Reduction Act, has benefited Ohioans on Medicare by reducing their insulin costs. Senator Brown emphasized his ongoing efforts to extend this price cap to all Americans.

Support for Affordable Insulin

Senator Brown has long been a champion for lowering insulin costs for all Ohioans. He is actively supporting legislation to cap insulin prices at $35 for everyone. Brown also advocated for extending the $35 monthly cap to all Americans through an amendment to the Inflation Reduction Act.

Testimonials of Gratitude

Ray Carlson, the owner of RC Outsourcing and RC Compounding Services, expressed his appreciation for Senator Brown’s initiatives in reducing drug prices and ensuring patient safety. Ohioans Mike and Kathleen Heinzer shared how the $35 insulin cap has significantly eased their financial burden, allowing them to afford their medication without worry.

Legislative Achievements

In the Inflation Reduction Act, Senator Brown successfully advocated for provisions that allow Medicare to negotiate directly with pharmaceutical companies, aiming to lower healthcare and prescription drug costs for Ohioans. He also ensured that companies increasing prices faster than inflation must provide rebates to reduce costs for patients and taxpayers.

In addition to his work on the Inflation Reduction Act, Senator Brown has been at the forefront of efforts to lower drug costs for seniors. He has pushed for reforms in pharmacy benefit manager practices to address high drug prices and introduced bipartisan legislation to reduce out-of-pocket costs for chronic condition medicines.

Senator Brown’s dedication to lowering prescription drug costs is evident in his bipartisan Pharmacy DIR Reform to Reduce Senior Drug Costs Act, which aims to eliminate retroactive fees imposed by PBMs and assess all pharmacy price concessions at the point of sale. Sections of this bill were included in legislation passed by the Senate Finance Committee.

Join the Fight for Affordable Insulin

Senator Brown’s relentless efforts to lower insulin prices demonstrate his commitment to improving access to affordable healthcare for all Americans. Stay informed and support initiatives that promote fair pricing and patient well-being.

Read More of this Story at www.brown.senate.gov – 2024-04-01 18:07:59